Sandrine Faivre

20.8k citations
286 papers · 14.9k indexed · 9 hit papers · h-index 58
Topics
Hepatocellular Carcinoma Treatment and Prognosis (50 papers)Pancreatic and Hepatic Oncology Research (47 papers)Lung Cancer Treatments and Mutations (46 papers)

In The Last Decade

Sandrine Faivre

281 papers receiving 14.6k citations

Hit Papers

Safety, Pharmacokinetic, and Antitumor Activity of SU1124...200520262012201920052006200720052014250500750

Peers

Sandrine Faivre
Comparison fields: 5 of 153
  • Oncology 6.8k
  • Molecular Biology 6.7k
  • Pulmonary and Respiratory Medicine 3.4k
  • Cancer Research 2.2k
  • Pathology and Forensic Medicine 1.7k
Replace Howard S. Höchster with:
Howard S. Höchster United States
G. Milano France
Éric Raymond France
Antonio Russo Italy
Rosemarie Mick United States
Alexandra Giatromanolaki Greece
Patrick Schöffski Belgium
Michael I. Koukourakis Greece
Luis Paz‐Ares Spain
Jan B. Vermorken Belgium
Sandrine Faivre relative to Howard S. Höchster United States Howard S. Höchster's profile →
Citations per field
00.5×2.7×
Howard S. Höchster · 1×
Citations per year

Countries citing papers authored by Sandrine Faivre

Since Specialization
Citations

This map shows the geographic impact of Sandrine Faivre's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sandrine Faivre with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sandrine Faivre more than expected).

Fields of papers citing papers by Sandrine Faivre

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sandrine Faivre. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sandrine Faivre. The network helps show where Sandrine Faivre may publish in the future.

Co-authorship network of co-authors of Sandrine Faivre

This figure shows the co-authorship network connecting the top 25 collaborators of Sandrine Faivre. A scholar is included among the top collaborators of Sandrine Faivre based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sandrine Faivre. Sandrine Faivre is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 6
2 4
3 8
4 10
5 93
6 34
7 17
8 42
9
Cisplatin and fluorouracil with or without panitumumab in patients with recurrent or metastatic squamous-cell carcinoma of the head and neck (SPECTRUM): an open-label phase 3 randomised trialbreakdown →
314
10 20
11
Phase II Study of Cetuximab As First-Line Single-Drug Therapy in Patients With Unresectable Squamous Cell Carcinoma of the Skinbreakdown →
334
12 28
13
Evaluation of Progression-Free Survival by Blinded Independent Central Review in Patients With Progressive, Well-Differentiated Pancreatic Neuroendocrine Tumors Treated With Sunitinib or Placebo
2
14 71
15 44
16 1
17 209
18
[Non-AIDS-related malignancies: prognostic and treatment].
1
19
Tumeurs malignes non associées au VIH : pronostic et traitement
1
20 67

About Sandrine Faivre

Sandrine Faivre is a scholar working on Hepatology, Oncology and Otorhinolaryngology, having authored 286 papers that have together received 14.9k indexed citations. Recurring topics across this work include Hepatocellular Carcinoma Treatment and Prognosis (50 papers), Pancreatic and Hepatic Oncology Research (47 papers) and Lung Cancer Treatments and Mutations (46 papers). The work is most often cited by research in Oncology (6.8k citations), Otorhinolaryngology (916 citations) and Hepatology (1.6k citations). Sandrine Faivre has collaborated with scholars based in France, United States and Germany. Frequent co-authors include Éric Raymond, Jan M. Woynarowski, Guido Kroemer, Armand de Gramont, Annemilaï Tijeras‐Raballand, Stephen G. Chaney, Christophe Le Tourneau, Cindy Neuzillet, Esteban Cvitkovic and Jean‐Pierre Armand. Their work appears in journals such as Journal of Clinical Oncology, PLoS ONE and Hepatology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026